Structure and Function of Complexin
络合蛋白的结构和功能
基本信息
- 批准号:9751893
- 负责人:
- 金额:$ 33.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-15 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAssesBindingBiological AssayBrainC-terminalCommunicationDependenceDiseaseEquilibriumExhibitsExocytosisFluorescenceHydrophobicityIn VitroKineticsKnowledgeLipid BindingMeasurementMeasuresMediatingMembraneMental disordersMethodsModelingMolecularMolecular ConformationMusMutationNatureNervous System PhysiologyNeuronsOpticsPeriodicityPhospholipidsPlayPositioning AttributeProcessPropertyProtein IsoformsProtein RegionProteinsRegulationRoleSNAP receptorSpectrum AnalysisStructureSynaptic VesiclesTestingVesiclebasedesignfarnesylationflyin vivomutantnervous system disorderneurotransmissionneurotransmitter releasepresynaptic neuronsprotein functionsynaptic inhibitionvesicular release
项目摘要
Project Summary/Abstract:
The protein complexin plays a critical role in the regulation of SNARE mediated synaptic vesicle
exocytosis at presynaptic nerve terminals in the brain. Complexin functions both to inhibit spontaneous
synaptic vesicle fusion and to enhance synchronized fusion. The central helix domain of complexin is required
for both its inhibitory and its facilitatory functions, but additional regions of the protein, in particular the C-
terminal domain (CTD), which follows the central helix and the accessory helix, which immediately precedes
the central helix, are also required for complexin's full inhibitory function. Our objective is to understand the
molecular basis for the functional roles of the CTD and the accessory helix.
The CTD of complexin interacts with phospholipid membranes, and this interaction serves to localize
complexin to synaptic vesicles in vivo and is required for complexin's inhibitory function. Two motifs within the
CTD act to both localize complexin specifically to highly curved synaptic vesicle membranes and to activate
complexin's inhibitory activity only when bound to synaptic vesicles, but important questions remain regarding
the mechanisms by which membrane-binding contributes to complexin's inhibitory function. Specifically, the
structural basis for the curvature-dependent interactions of the two CTD motifs with membranes remain
unclear. In addition, many complexins feature a C-terminal CAAX box motif that leads to farnesylation, and the
membrane-binding properties of farnesylated complexins have not been explored. This proposal aims at filling
key gaps in our knowledge of how the structural features of membrane-bound complexin relate to the function
of the protein. To do this, two specific aims will be pursued. (1) To characterize the structural basis for the
membrane curvature-dependent structural transition of the amphipathic helix motif of complexin's CTD, to
assess the role of membrane curvature dependent helix formation in regulating complexin's inhibitory function
and to assess the influence of this transition on membrane binding affinity and kinetics. (2) To characterize the
structural basis for membrane interactions by both farnesylated and unmodified C-terminal motifs in
complexin's CTD, and to asses the functional implications of these interactions.
The accessory helix of complexin also contributes significantly to the inhibition of neurotransmitter
release. Recent results suggest that the accessory helix acts to nucleate and stabilize helical structure in the
central helix, and thereby facilitates the interactions of the central helix with SNARE proteins. In a third specific
aim (3) we will test this hypothesis by directly characterizing alterations in the helicity of the accessory and
central helices, measuring how such alterations influence SNARE binding in vitro, and correlating these
measurements with effects on complexin's inhibitory function in vivo.
Together these three aims will serve to elucidate the molecular basis for the roles of complexin's CTD
and accessory helix in the inhibition of neurotransmitter release.
项目总结/文摘:
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Spectroscopic Characterization of Structure-Function Relationships in the Intrinsically Disordered Protein Complexin.
本质无序蛋白质复合物结构-功能关系的光谱表征。
- DOI:10.1016/bs.mie.2018.08.005
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:Snead,David;Eliezer,David
- 通讯作者:Eliezer,David
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Eliezer其他文献
David Eliezer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Eliezer', 18)}}的其他基金
Structure and Function of Protein Disorder in Membrane Trafficking and Organization
膜运输和组织中蛋白质紊乱的结构和功能
- 批准号:
10609819 - 财政年份:2020
- 资助金额:
$ 33.12万 - 项目类别:
Structure and Function of Protein Disorder in Membrane Trafficking and Organization
膜运输和组织中蛋白质紊乱的结构和功能
- 批准号:
10395495 - 财政年份:2020
- 资助金额:
$ 33.12万 - 项目类别:
Presentation of Structural Determinants of the 2F5 Neutralization Epitope
2F5 中和表位的结构决定因素的介绍
- 批准号:
7893972 - 财政年份:2009
- 资助金额:
$ 33.12万 - 项目类别:
Presentation of Structural Determinants of the 2F5 Neutralization Epitope
2F5 中和表位的结构决定因素的介绍
- 批准号:
7609151 - 财政年份:2008
- 资助金额:
$ 33.12万 - 项目类别:
相似海外基金
Apoptosis assay to asses the anti-tumour effects of RP215 and GHR 106 monoclonal antibodies
通过细胞凋亡测定评估 RP215 和 GHR 106 单克隆抗体的抗肿瘤作用
- 批准号:
412165-2011 - 财政年份:2011
- 资助金额:
$ 33.12万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)
New Mexico Pregnancy Risk Asses Monitoring Sys, Maternal Child Hlth Epidemi......
新墨西哥州妊娠风险评估监测系统,母婴健康流行……
- 批准号:
7232729 - 财政年份:2006
- 资助金额:
$ 33.12万 - 项目类别:
New Mexico Pregnancy Risk Asses Monitoring Sys, Maternal Child Hlth Epidemi......
新墨西哥州妊娠风险评估监测系统,母婴健康流行……
- 批准号:
7406805 - 财政年份:2006
- 资助金额:
$ 33.12万 - 项目类别:
New Mexico Pregnancy Risk Asses Monitoring Sys, Maternal Child Hlth Epidemi......
新墨西哥州妊娠风险评估监测系统,母婴健康流行……
- 批准号:
7803588 - 财政年份:2006
- 资助金额:
$ 33.12万 - 项目类别:
Continuation of NC Pregnancy Risk Asses Monitoring Sys. Sys Collects Risk Fact...
北卡罗来纳州怀孕风险评估监测系统的延续。
- 批准号:
7807200 - 财政年份:2006
- 资助金额:
$ 33.12万 - 项目类别:
Continuation of NC Pregnancy Risk Asses Monitoring Sys. Sys Collects Risk Fact...
北卡罗来纳州怀孕风险评估监测系统的延续。
- 批准号:
7173492 - 财政年份:2006
- 资助金额:
$ 33.12万 - 项目类别:
Continuation of NC Pregnancy Risk Asses Monitoring Sys. Sys Collects Risk Fact...
北卡罗来纳州怀孕风险评估监测系统的延续。
- 批准号:
7226762 - 财政年份:2006
- 资助金额:
$ 33.12万 - 项目类别:
Continuation of NC Pregnancy Risk Asses Monitoring Sys. Sys Collects Risk Fact...
北卡罗来纳州怀孕风险评估监测系统的延续。
- 批准号:
7406806 - 财政年份:2006
- 资助金额:
$ 33.12万 - 项目类别:
New Mexico Pregnancy Risk Asses Monitoring Sys, Maternal Child Hlth Epidemi......
新墨西哥州妊娠风险评估监测系统,母婴健康流行……
- 批准号:
7173499 - 财政年份:2006
- 资助金额:
$ 33.12万 - 项目类别:
Collaborative: A Measurement Program in Sibera o Asses Disturbance-Driven Changes in Arctic Carbon Fluxes (RAISE)
协作:西伯利亚的测量计划 o 评估干扰驱动的北极碳通量变化 (RAISE)
- 批准号:
0451413 - 财政年份:2005
- 资助金额:
$ 33.12万 - 项目类别:
Standard Grant














{{item.name}}会员




